Skip to content

Expanding ECMO Horizons: Shock and Temporary Mechanical Circulatory Support

This program happened in the past, and no dates are currently scheduled.

Select this button to navigate the sections of this page

Conference ID

D7086

Purpose/Overview

This activity is designed to discuss, define and resolve outstanding clinical and regulatory issues related to extracorporeal membrane oxygenation (ECMO) therapy. Discussions will be led by international leaders in the field. New technologies and advanced techniques for cannulation and circuitry will be presented. Explore unique and effective methods for managing long-term ECMO patients in the intensive care unit.

Audience

Cardiothoracic surgeons; heart and lung transplant surgeons; cardiologists, including interventional, acute care, heart failure, and heart transplant; cardiac and cardiothoracic fellows; pulmonologists; intensivists; cardiovascular/pulmonary/critical care anesthesiologists; nurse practitioners; physician assistants; respiratory therapists; and perfusion, nursing, and ECMO teams can benefit from attending this activity.

Agenda

  • 7:30 a.m. | Check-In/Exhibits
  • 7:55 a.m. | Welcome and Overview
    Christoph Brehm, MD
  • 8 a.m. |
    Session 1: Cardiogenic Shock

    Update on Cardiogenic Shock – SCAI Staging and SHARC Classification
    Christoph Brehm, MD

    Objectives
    • Define cardiogenic shock.
    • Review the epidemiology and outcomes.
    • Explain the SCAI shock staging system.
    • Summarize the SHARC classification.
    • Apply staging systems to clinical practice.

    ECMO & Cardiac Arrest
    Jordan Schooler, MD, PhD

    Objectives
    • Review application of ECMO in cardiac arrest.
    • Describe current evidence on ECPR efficacy and criteria.

    Pulmonary Embolism: Pathophysiology and Management
    David Chu, MD

    Objectives
    • Recognize common clinical presentations of acute pulmonary embolism and associated pathophysiology.
    • Demonstrate the ability to provide initial management for patients presenting with intermediate-high risk or high-risk acute pulmonary embolism.
    • Review our institution’s approach to acute pulmonary embolism patients including the Pulmonary Embolism Response Team.

    Interventions in Pulmonary Embolism: Optimizing Outcomes with Invasive Therapies
    Chad Zack, MD

    Objectives
    • Evaluate multidisciplinary PERT team workflows to risk-stratify and manage patients with intermediate and high-risk pulmonary embolism.
    • Analyze the impact invasive management of pulmonary embolism on future practice patterns.

    Session 1 Panel Discussion
    Moderator: Chad Zack, MD

  • 9:45 a.m. | Break/Exhibits
  • 10:15 a.m. |
    Session 2: Temporary Mechanical Circulatory Support Devices & Pharmacologic Approaches to ECMO

    End Stage Heart Failure Gender Differences on Survival
    Nandini Nair, MD, PhD, MHL, CPE, FACC, FSVM, FACP, FHFSA, FAHA

    Objectives
    • Identify gender differences in survival in acute and chronic heart failure.
    • Describe the pathophysiology underlying gender differences in heart failure survival.

    Role of Temporary Bridging Devices in the Management of Heart Failure
    Balakrishnan Mahesh, MBBS, PhD

    Objectives
    • List indications for these devices.
    • Discuss techniques of insertion, immediate results, and mid-term outcomes.

    Venoarterial Extracorporeal Membrane Oxygenation vs. Percutaneous Ventricular Assist Devices in Cardiogenic Shock
    Amit Prasad, MD

    Objectives
    • Identify appropriate indications for the use of venoarterial extracorporeal membrane oxygenation in the management of cardiogenic shock.
    • Discuss clinical scenarios in which venoarterial extracorporeal membrane. oxygenation may be preferred over percutaneous left ventricular assist devices for temporary mechanical circulatory support.

    Pharmacologic Approaches to ECMO
    Christine Shulenberger, PharmD, BCCP

    Objectives
    • Identify at least three medications that are affected by the ECMO circuit and the properties that affect dosing.
    • When given a patient case, determine appropriate dosing and monitoring of medications.

    Session 2 Panel Discussion
    Moderator: Nandini Nair, MD, PhD, MHL, CPE, FACC, FSVM, FACP, FHFSA, FAHA

  • Noon | Lunch/Exhibits
  • 1 p.m. |
    Session 3: Critical Care Management of Patients with Temporary Mechanical Circulatory Support Devices

    Advanced Practice Provider: The Expert Role and Management of ECMO and Temporary Mechanical Circulatory Support Devices
    Brianna Helm, MSN, CCRN, AGACNP-BC, and Samantha Henry, MSN, CCRN, ACNPC-AG

    Objectives
    • Describe the importance of the advanced practice provider in critical care units.
    • Explain the advanced practice provider’s role in management of ECMO patients.
    • Discuss emergency management of venoarterial and venovenous ECMO.

    ECMO Competency Pathways: Building a Skilled Clinical Team
    Michelle Peters, MSN, RN, CHFN

    Objectives
    • Describe key roles of the ECLS Clinical Team, highlighting the competent and advanced ECMO RN pathways.
    • Explore structured training, simulation, and ongoing competency strategies that support safe, high-quality ECLS care.

    Early Mobility of Patients with Mechanical Circulatory Support Devices
    Katie Glenn, RN, BSN, CCRN; Brittany Rohrer MS, OTR/L; and Alyssa Wiekrykas, DPT

    Objectives
    • Identify appropriate candidates for early mobility among patients with mechanical circulatory support devices, outline safety parameters, and apply evidence-based strategies to support mobilization while minimizing device-related complications.
    • Explain the importance and benefits of early mobilization for intensive care unit patients receiving mechanical circulatory support, including its impact on patient outcomes and recovery.

    Session 3 Panel Discussion
    Moderator: Michelle Peters, MSN, RN, CHFN

  • 2:15 p.m. | Break/Exhibits
  • 2:30 p.m. |
    Session 4: Neurocritical Diagnoses, Brain Death Determination, and Ethical Considerations

    Neurocritical Complications on ECMO
    Sprague William Hazard, MD

    Objectives
    • TBD

    Using Carbogen to Perform Apnea Testing in ECMO-Supported Patients
    Jefferson Mixell, MBA, RRT, RRT-ACCS

    Objectives
    • Explain how carbogen enables apnea testing in patients supported by ECMO.
    • Describe key considerations for safely performing a carbogen apnea test during ECMO.

    Effectively Partnering with Palliative Care in Patients Supported on ECMO
    James Andrew “Andy” Probolus, MD

    Objectives
    • Recognize appropriate language to describe Palliative Care involvement in patients supported on ECMO.
    • Describe the potential roles that a Palliative Care team can play with patients supported on ECMO, including support, communication, facilitating difficult conversations and decision making.

    Ethical Controversies in Brain Death Declaration
    Rebecca Volpe, PhD, HEC-C

    Objectives
    • Describe various ethical controversies that exist regarding the declaration of brain death and subsequent withdrawal of life sustaining treatment.
    • Apply the ethical controversies to the care of ECMO patients.

    Session 4 Panel Discussion
    Moderator: TBD

  • 4 p.m. | Closing Remarks/Adjournment
    Christoph Brehm, MD

Committee

ELSO logo with tiny text around itChristoph Brehm, MD, Course Director

Angela Lambert, DNP
Allana Langley, MSN
Michelle Peters, MSN, RN, CHFN
Kelly Rothbart, CRNP
Melissa Weigard, RRT
Karl Woitas, CCP

Presenters

Christoph Brehm, MD
Associate Professor, Department of Surgery
Penn State Heart and Vascular Institute
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

David Chu, MD
Associate Professor, Department of Medicine
Division of Pulmonary, Allergy and Critical Care Medicine
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Katie Glenn, RN, BSN, CCRN
Clinical Staff Leader
Heart and Vascular Institute Critical Care Unit
Penn State Health Milton S. Hershey Medical Center

Sprague William Hazard, MD
Professor, Department of Anesthesiology and Perioperative Medicine
Chief, Division of Neuro-Anesthesia
Division of Critical Care Anesthesia
Professor, Department of Neurosurgery
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Brianna Helm, MSN, CCRN, AGACNP-BC
Nurse Practitioner Critical Care – Intensivist Services
Penn State Health Milton S. Hershey Medical Center

Samantha Henry, MSN, CCRN, ACNPC-AG
Nurse Practitioner Critical Care – Intensivist Services
Penn State Health Milton S. Hershey Medical Center

Balakrishnan Mahesh, MBBS, PhD
Associate Professor, Department of Surgery
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Jefferson Mixell, MBA, RRT, RRT-ACCS
Manager Respiratory Care
Penn State Health Milton S. Hershey Medical Center

Nandini Nair, MD, PhD, MHL, CPE, FACC, FSVM, FACP, FHFSA, FAHA
Professor, Department of Medicine
Medical Director, MCS/Cardiac Transplant
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Michelle Peters, MSN, RN, CHFN
ECMO Program Coordinator
Heart and Vascular Institute Critical Care Unit
Penn State Health Milton S. Hershey Medical Center

Amit Prasad, MD
Associate Professor, Department of Anesthesiology and Perioperative Medicine
Associate Vice Chair of Education
Penn State Heart and Vascular Institute
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

James Andrew “Andy” Probolus, MD
Assistant Professor, Department of Medicine
Division of General Internal Medicine
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Brittany Rohrer MS, OTR/L
Occupational Therapist Level 2
Occupational Therapy
Penn State Health Milton S. Hershey Medical Center

Jordan Schooler, MD, PhD
Associate Professor, Department of Surgery
Associate Professor, Department of Emergency Medicine
Penn State Heart and Vascular Institute
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Christine Shulenberger, PharmD, BCCP
Clinical Pharmacy Specialist – Heart and Vascular CCU
Penn State Health Milton S. Hershey Medical Center

Rebecca Volpe, PhD, HEC-C
Associate Professor, Department of Humanities
Director, Clinical Ethics Consultation Service
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Alyssa Wiekrykas, DPT
Physical Therapist Level 2
Physical Therapy
Penn State Health Milton S. Hershey Medical Center

Chad Zack, MD
Assistant Professor, Department of Medicine
Division of Cardiology
Penn State Heart and Vascular Institute
Penn State College of Medicine
Penn State Health Milton S. Hershey Medical Center

Credit

AMA

Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses Using AMA Credit

Nurses will receive a certificate from Penn State College of Medicine verifying their participation in up to 6.25 hours of approved continuing medical education. Continuing education activities which are approved by accredited institutions of higher education and that are relevant to patient care or professional nursing meet the requirements of mandatory continuing education for registered nurses in Pennsylvania, as required by the Pennsylvania State Board of Nursing. The Board of Nursing recommends that nurses retain their certificates for a period of at least five years. Additional information is available through the State Board of Nursing.

These credits meet the criteria set by the ANCC, American Nurses Credentialing Center as contact hours that are acceptable for renewal certification. Additional information is available through the American Nurses Credentialing Center.

Logo for AARC CRCE - Continuing Respiratory Care Education

American Association For Respiratory Care

This program has been approved for 6.25 contact hours Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care
Course #195323000.

American Board Of Cardiovascular Perfusion

This activity has been approved for 7.50 Category 1 CEU hours by the American Board of Cardiovascular Perfusion.

Fees

$150 Physicians
$120 Advanced Practice Providers
$100 Others

The fee includes the cost of instruction, online handout materials and all listed meals.

Payment is required at the time of registration. If you have any questions or concerns, please email us at ContinuingEd@pennstatehealth.psu.edu.

Registrations received after Thursday, Nov. 13, will incur a $25 late fee.

Cancellations received after Friday, Nov. 7, will be assessed a $25 processing fee.

No refunds will be made for cancellations received after Tuesday, Nov. 11.

Accommodations

Accommodations are the responsibility of the program participant. A list of Hershey area lodging is available upon request or online.

Local Attractions

Join us in Hershey

Hershey is conveniently located in central Pennsylvania, just 90 minutes from Baltimore and Philadelphia, two hours from Washington, D.C., and three hours from New York City.

Evaluation

A completed evaluation is required in order to receive a certificate for attending this activity. Please complete and submit the evaluation within the specified time frame.

Cancellations

The University reserves the right to cancel or postpone any course or activity because of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the University will refund any program registration fees paid but cannot be held responsible for any related costs, charges or expenses, including cancellation/change charges assessed by airlines or travel agencies.

Program registrants who are experiencing illness or have been exposed to anyone who is ill should contact the Continuing Education office before attending any in-person activities.

Changes

Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.

COVID-19

On-campus educational activities provided by Penn State College of Medicine Continuing Education are required to follow healthcare facility guidelines. Off-campus events provided by Penn State College of Medicine Continuing Education follow the COVID-19 requirements of that venue. We ask that all participants respect that some attendees may still choose to wear masks for activities. Check the venue website for the latest requirements and recommendations. Please do not attend this activity if you have symptoms or have been exposed to someone with COVID-19. By attending the activity, you attest that you do not have any symptoms suggestive of COVID-19, which may include fever, cough, shortness of breath, sore throat, loss of taste, loss of smell or any other sign of illness.

Access (ADA)

Penn State encourages people with disabilities to participate in its programs and activities. Participants who anticipate needing any type of special accommodation or who have questions about the physical access provided should contact the Continuing Education office at least one week in advance of participation or visit.

Disclosure and Conflict of Interest (COI and Educational Balance)

It is Penn State policy to ensure balance, independence, objectivity and scientific rigor in all educational activities. Penn State has a process in place to mitigate any relevant financial relationships with commercial companies disclosed by faculty, course directors and planning committee members. Complete disclosure information will be provided to participants at the beginning of the activity.

University Nondiscrimination Policy

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission and employment without regard to personal characteristics not related to ability, performance or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment or retaliation against faculty, staff or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; 814-863-0471 (TTY). US M.Ed. D7086

Jump to ...